We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Stocks ended mostly higher today, though not in any inspiring fashion - more like the way a snake clears a hurdle.

This seed funding round was led by Bee Partners with participation from Julien Chaumond (Hugging Face co-founder), ...

Guggenheim analyst Michael Schmidt maintained a Buy rating on Exelixis (EXEL – Research Report) on March 26 and set a price target of $42.00.